Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum]

Abstract

Gomari H, Forouzandeh Moghadam M, Soleimani M, Ghavami M, Khodashenas S. Int J Nanomedicine. 2019;14:5679–5690.The authors of this paper have advised that by their mistake, they omitted an important note from the Acknowledgments section on page 5688.Read the original article